Conflicts of interest
ONCOLOGY
Hideko Yamauchi reports research funding from AstraZeneca and Eiken. Masakazu Toi reports research grants from AFI technology, Astellas, AstraZeneca, Chugai, Daiichi-Sankyo, Eisai, Eli Lilly and companies, GL Science, JBCRG assoc., KBCRN assoc., Luxonus, Nippon Kayaku, Pfizer, Sanwa Shurui, Shimadzu, Shionogi, Taiho, Takeda, and Yakult; lecture chair or honoraria from AstraZeneca, Chugai, Daiichi-Sankyo, Devicore medical Japan, Eisai, Eli Lilly and companies, Exact Science, Kyowa-Kirin, Merck Sharp & Dohme Corp, Nippon Kayaku, Novartis, Pfizer, Shimadzu, Sysmex, Taiho, Takeda, and Yakult; participation on advisory boards with Athenex Oncology, Bertis, Bristol-Myers Squibb, Daiichi-Sankyo, Eli Lilly and companies, Kansai Medical Net, and Terumo; being a member of the board of directors (with no salary) for JBCRG assoc., KBCRN assoc., and NPO org. OOTR; being an associate editor for 